Toll-like receptors in multiple sclerosis.
Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal pathology. The exact causes of MS are unknown, but environmental factors including pathogens are believed to contribute to the development of disease. Toll-like receptors (TLRs) are a family of receptors important in pathogen recognition and host defense. TLRs are expressed by a variety of peripheral immune cells as well as resident cells of the CNS. Studies indicate that TLRs play a significant role in modulating MS, as well as experimental autoimmune encephalomyelitis (EAE), an animal model of MS. This review will discuss the current understanding of the role of TLRs in modulating EAE and MS.
Racke
Michael K
MK
Department of Neurology, The Ohio State University Medical Center, 1654 Upham Drive, 445 Means Hall, Columbus, OH 43210, USA.
Drew
Paul D
PD
D000818:Animals; D015551:Autoimmunity / Q000276:immunology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology*; D006801:Humans; D009103:Multiple Sclerosis / Q000276:immunology*; D051193:Toll-Like Receptors / Q000276:immunology*
D051193:Toll-Like Receptors
Nature. 1996 Oct 3;383(6599):443-6
8837778
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9
12824464
J Immunol. 2005 Jan 15;174(2):808-16
15634902
Nature. 1999 Jun 24;399(6738 Suppl):A40-7
10392579
Int Rev Neurobiol. 2007;79:73-97
17531838
Arch Neurol. 2005 Sep;62(9):1345-56
16157741
Curr Opin Immunol. 2007 Feb;19(1):39-45
17129718
Science. 2003 Aug 1;301(5633):640-3
12855817
J Neurol Sci. 1982 Nov-Dec;57(1):105-10
7153781
J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21
12430718
Nat Rev Immunol. 2002 Feb;2(2):85-95
11910899
Curr Biol. 2000 Sep 21;10(18):1139-42
10996797
Infect Immun. 2006 Aug;74(8):4841-8
16861672
J Immunol. 1995 Nov 15;155(10):5011-7
7594508
Curr Protoc Neurosci. 2001 May;Chapter 9:Unit9.7
18428555
Annu Rev Immunol. 2003;21:335-76
12524386
J Immunol. 2003 Mar 15;170(6):2833-42
12626533
Neurology. 1998 Feb;50(2):571-2
9484408
J Exp Med. 2002 Dec 16;196(12):1639-44
12486106
N Engl J Med. 2006 Mar 2;354(9):942-55
16510748
Curr Opin Immunol. 1997 Dec;9(6):831-8
9492986
Glia. 2006 May;53(7):688-95
16482523
Neurol Clin. 1983 Aug;1(3):765-82
6209540
J Immunol. 1992 Oct 1;149(7):2496-505
1527389
N Engl J Med. 2008 Feb 14;358(7):676-88
18272891
J Clin Invest. 2008 May;118(5):1680-90
18382764
Nat Med. 1997 Oct;3(10):1133-6
9334726
J Exp Med. 2003 Oct 6;198(7):1043-55
14517278
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6299-304
16603631
Brain Res Rev. 2007 Jun;54(2):274-85
17383006
J Immunol. 2008 Apr 1;180(7):4763-73
18354200
J Clin Invest. 1999 Sep;104(5):599-610
10487774
J Clin Invest. 2006 Feb;116(2):456-64
16440059
Nature. 2001 Apr 26;410(6832):1099-103
11323673
Clin Microbiol Rev. 1993 Oct;6(4):382-427
8269393
Trends Immunol. 2005 Jun;26(6):289-91
15922942
Am J Pathol. 2006 Nov;169(5):1671-85
17071591
J Neuroimmunol. 2006 Mar;172(1-2):94-103
16360885
Arch Physiol Biochem. 2007 Jun;113(3):124-30
17922308
Lab Invest. 1981 Sep;45(3):278-84
6792424
Clin Neurol Neurosurg. 2004 Jun;106(3):246-8
15177777
J Exp Med. 2000 Aug 21;192(4):595-600
10952730
Nature. 2006 Jan 12;439(7073):204-7
16306937
Ann Neurol. 1992 Mar;31(3):333-6
1637140
Science. 1996 Feb 23;271(5252):1128-31
8599092
J Neurol. 1997 Mar;244(3):153-9
9050955
Annu Rev Immunol. 1992;10:153-87
1375472
Can J Neurol Sci. 1993 Feb;20(1):17-29
8467424
J Exp Med. 1998 Jun 15;187(12):2097-101
9625770
J Immunol. 2001 Aug 1;167(3):1803-8
11466406
Immunol Today. 1996 May;17(5):225-31
8991384
Cell. 1993 Feb 26;72(4):551-60
7679952
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10976-80
16043704
J Immunol. 2001 Nov 15;167(10):5887-94
11698465
Neurology. 1995 Jul;45(7):1268-76
7617181
Cell Mol Life Sci. 2008 Sep;65(17):2702-20
18516496
Cell. 1987 Sep 11;50(6):819-20
3621346
J Immunol. 2000 Jan 15;164(2):554-7
10623793
J Immunol. 2004 Dec 1;173(11):7070-7
15557205
Lancet. 1986 Apr 12;1(8485):815-9
2870312
J Clin Invest. 2004 Apr;113(7):990-7
15057305
J Neuroimmunol. 2007 Apr;185(1-2):115-22
17341432
Ann Neurol. 1994;36 Suppl:S25-8
8017885
Am J Phys Med Rehabil. 1995 Nov-Dec;74(6):415-8
8534384
Immunol Rev. 1999 Jun;169:241-53
10450521
Nat Immunol. 2007 Sep;8(9):913-9
17712344
Ann Neurol. 1996 Mar;39(3):285-94
8602746
Nat Immunol. 2003 Feb;4(2):161-7
12539043
Nat Med. 2005 Mar;11(3):335-9
15735651
J Neurochem. 2007 Dec;103(5):1801-10
17727629
Brain Pathol. 2002 Jul;12(3):308-19
12146799
Annu Rev Immunol. 2004;22:457-83
15032585
Int Immunol. 2005 Jan;17(1):1-14
15585605
Nat Immunol. 2002 Feb;3(2):196-200
11812998
Annu Rev Immunol. 1989;7:145-73
2523712
J Neurosci. 2002 Apr 1;22(7):2478-86
11923412
Brain. 1986 Apr;109 ( Pt 2):325-44
3456817
Int Rev Neurobiol. 2007;79:13-42
17531836
J Immunol. 2006 Dec 1;177(11):7505-9
17114417
Nature. 2008 Jun 19;453(7198):1051-7
18563156
Cell Immunol. 1989 Nov;124(1):132-43
2478300
Lancet. 1985 Jun 8;1(8441):1313-5
2860501
Immunol Today. 1994 Aug;15(8):356-61
7916948
J Immunol. 2000 Jun 1;164(11):5683-8
10820244
Mol Cell. 1998 Aug;2(2):253-8
9734363
J Immunol. 2007 Feb 1;178(3):1904-13
17237441
J Biol Chem. 1997 Aug 22;272(34):21540-7
9261174
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5567-72
11960013
Immunity. 1999 Jul;11(1):115-22
10435584
Nat Immunol. 2007 Feb;8(2):172-80
17206145
Nat Immunol. 2003 May;4(5):491-6
12692549